Merrick I. Ross
Active 1990–2025
- Also published as
- Merrick I Ross
- 212
- Papers
- 51,212
- Citations
- 116
- h-index
- 210
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine59.5%
- Biochemistry, Genetics and Molecular Biology30.3%
- Immunology and Microbiology6.5%
- Engineering1.6%
- Computer Science0.5%
- Agricultural and Biological Sciences0.2%
- Other1.4%
Topics
- Cutaneous Melanoma Detection and Management9.7%
- Cancer Immunotherapy and Biomarkers7.3%
- Immunotherapy and Immune Responses6%
- CAR-T cell therapy research5.4%
- Breast Cancer Treatment Studies5.2%
- Melanoma and MAPK Pathways5.2%
- Other61.2%
Coauthors
- Jeffrey E. Gershenwald77
- Kelly K. Hunt54
- Henry M. Kuerer51
- Jeffrey E. Lee43
- S. Eva Singletary41
- Frederick C. Ames37
- Barry W. Feig34
- Gildy V. Babiera32
- Funda Meric‐Bernstam29
- Kelly M. McMasters29
- Paul F. Mansfield28
- Douglas S. Reintgen27
- Janice N. Cormier26
- Charles M. Balch23
- Víctor G. Prieto23
- Thomas A. Buchholz20
- Anthony Lucci18
- Daniel G. Coit18
- John F. Thompson17
- John M. Kirkwood15
- Michael J. Edwards15
- Gabriel N. Hortobágyi14
- Michael A. Davies14
- R. Dirk Noyes14
All papers
- Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Authors: Sapna P. Patel, Megan Othus, Yuanbin Chen, G. Paul Wright, Kathleen J. Yost, John Hyngstrom, Siwen Hu‐Lieskovan, Christopher D. Lao, Leslie A. Fecher, Thach‐Giao Truong, Jennifer L. Eisenstein, Sunandana Chandra, Jeffrey A. Sosman, Kari Kendra, Richard C. Wu, Craig Devoe, Gary B. Deutsch, Aparna Hegde, Maya Khalil, Ankit Mangla, Amy M. Reese, Merrick I. Ross, Andrew Poklepovic, Giao Q. Phan, Adedayo A. Onitilo, Demet G. Yasar, Benjamin Powers, Gary C. Doolittle, Gino K. In, Niels Kokot, Geoffrey T. Gibney, Michael B. Atkins, Montaser Shaheen, James Warneke, Alexandra P. Ikeguchi, Jose Eugenio Najera, Bartosz Chmielowski, Joseph G. Crompton, Justin D. Floyd, Eddy C. Hsueh, Kim Margolin, Warren Chow, Kenneth F. Grossmann, Eliana Dietrich, Víctor G. Prieto, Michael Lowe, Elizabeth I. Buchbinder, John M. Kirkwood, Larissa A. Korde, James Moon, Elad Sharon, Vernon K. Sondak, Antoni Ribas - New England Journal of Medicine 2023 cited by 827
- Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Authors: Christine N. Spencer, Jennifer L. McQuade, Vancheswaran Gopalakrishnan, John A. McCulloch, Marie Vétizou, Alexandria P. Cogdill, Md Abdul Wadud Khan, Xiaotao Zhang, Michael G. White, Christine B. Peterson, Matthew C. Wong, Golnaz Morad, Theresa Rodgers, Jonathan H. Badger, Beth A. Helmink, Miles C. Andrews, Richard R. Rodrigues, Andrey Morgun, Young S. Kim, Jason Roszik, Kristi L. Hoffman, Jiali Zheng, Yifan Zhou, Yusra B. Medik, Laura M. Kahn, Sarah B. Johnson, Courtney W. Hudgens, Khalida Wani, Pierre-Olivier Gaudreau, Angela L. Harris, Mohamed A. Jamal, Erez N. Baruch, Eva Pérez‐Guijarro, Chi‐Ping Day, Glenn Merlino, Barbara Pazdrak, Brooke S. Lochmann, Robert Szczepaniak‐Sloane, Reetakshi Arora, Jaime Anderson, Chrystia M. Zobniw, Eliza Posada, Elizabeth Sirmans, Julie M. Simon, Lauren E. Haydu, Elizabeth M. Burton, Linghua Wang, Minghao Dang, Karen Clise-Dwyer, Sarah Schneider, Thomas Chapman, Nana-Ama A.S. Anang, Sheila Duncan, Joseph Toker, Jared Malke, Isabella C. Glitza, Rodabe N. Amaria, Hussein A. Tawbi, Adi Diab, Michael K. Wong, Sapna P. Patel, Scott E. Woodman, Michael A. Davies, Merrick I. Ross, Jeffrey E. Gershenwald, Jeffrey E. Lee, Patrick Hwu, V. Behrana Jensen, Yardena Samuels, Ravid Straussman, Nadim J. Ajami, Kelly C. Nelson, Luigi Nezi, Joseph F. Petrosino, P. Andrew Futreal, Alexander J. Lazar, Jianhua Hu, Robert R. Jenq, Michael T. Tetzlaff, Yan Yan, Wendy S. Garrett, Curtis Huttenhower, Padmanee Sharma, Stephanie S. Watowich, James P. Allison, Lorenzo Cohen, Giorgio Trinchieri, Carrie R. Daniel, Jennifer A. Wargo - Science 2021 cited by 932
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Authors: Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio, Thomas Amatruda, Neil Senzer, Jason Chesney, Keith A. Delman, Lynn E. S̄pitler, Igor Puzanov, Sanjiv S. Agarwala, Mohammed Milhem, Lee D. Cranmer, Brendan D. Curti, Karl D. Lewis, Merrick I. Ross, Troy H. Guthrie, Gerald P. Linette, Gregory A. Daniels, Kevin J. Harrington, Mark R. Middleton, Wilson H. Miller, Jonathan S. Zager, Yining Ye, Bin Yao, Li Ai, Susan Doleman, Ari M. Vanderwalde, Jennifer Gansert, Robert S. Coffin - Journal of Clinical Oncology 2015 cited by 2,598
- Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Authors: Jeffrey E. Gershenwald, Richard A. Scolyer, Kenneth R. Hess, Vernon K. Sondak, Georgina V. Long, Merrick I. Ross, Alexander J. Lazar, Mark B. Faries, John M. Kirkwood, Grant A. McArthur, Lauren E. Haydu, Alexander M.M. Eggermont, Keith T. Flaherty, Charles M. Balch, John F. Thompson - CA A Cancer Journal for Clinicians 2017 cited by 2,286
- Neoadjuvant relatlimab and nivolumab in resectable melanoma
Authors: Rodabe N. Amaria, Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala, Isabella C. Glitza, Fei Duan, Denái R. Milton, Klaus J. Busam, Lauren Simpson, Jennifer L. McQuade, Michael K. Wong, Jeffrey E. Gershenwald, Jeffrey E. Lee, Ryan P. Goepfert, Emily Z. Keung, Sarah B. Fisher, Allison Betof Warner, Alexander N. Shoushtari, Margaret K. Callahan, Daniel Coit, Edmund K. Bartlett, Danielle M. Bello, Parisa Momtaz, Courtney Nicholas, Aidi Gu, Xuejun Zhang, Brinda Rao Korivi, Madhavi Patnana, Sapna P. Patel, Adi Diab, Anthony Lucci, Víctor G. Prieto, Michael A. Davies, James P. Allison, Padmanee Sharma, Jennifer A. Wargo, Charlotte E. Ariyan, Hussein A. Tawbi - Nature 2022 cited by 332
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Authors: Rodabe N. Amaria, Sangeetha M. Reddy, Hussein A. Tawbi, Michael A. Davies, Merrick I. Ross, Isabella C. Glitza, Janice N. Cormier, Carol M. Lewis, Wen-Jen Hwu, Ehab Hanna, Adi Diab, Michael K. Wong, Richard E. Royal, Neil D. Gross, Randal S. Weber, Stephen Y. Lai, Richard A. Ehlers, Jorge Blando, Denái R. Milton, Scott E. Woodman, Robin Kageyama, Daniel K. Wells, Patrick Hwu, Sapna P. Patel, Anthony Lucci, Amy C. Hessel, Jeffrey E. Lee, Jeffrey E. Gershenwald, Lauren Simpson, Elizabeth M. Burton, Liberty Posada, Lauren E. Haydu, Linghua Wang, Shaojun Zhang, Alexander J. Lazar, Courtney W. Hudgens, Vancheswaran Gopalakrishnan, Alexandre Reuben, Miles C. Andrews, Christine N. Spencer, Víctor G. Prieto, Padmanee Sharma, James P. Allison, Michael T. Tetzlaff, Jennifer A. Wargo - Nature Medicine 2018 cited by 826
- Final Version of 2009 AJCC Melanoma Staging and Classification
Authors: Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong, John F. Thompson, Michael B. Atkins, David R. Byrd, Antônio C. Buzaid, Alistair J. Cochran, Daniel G. Coit, Shouluan Ding, Alexander M.M. Eggermont, Keith T. Flaherty, Phyllis A. Gimotty, John M. Kirkwood, Kelly M. McMasters, Martín C. Mihm, Donald L. Morton, Merrick I. Ross, Arthur J. Sober, Vernon K. Sondak - Journal of Clinical Oncology 2009 cited by 4,570
- Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
Authors: Jason Chesney, Igor Puzanov, Frances A. Collichio, Parminder Singh, Mohammed Milhem, John A. Glaspy, Omid Hamid, Merrick I. Ross, Philip Friedlander, Claus Garbe, Theodore F. Logan, Axel Hauschild, Célèste Lebbé, Lisa Chen, Jaeyeon Kim, Jennifer Gansert, Robert H.I. Andtbacka, Howard L. Kaufman - Journal of Clinical Oncology 2017 cited by 617
- Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma
Authors: M.T. Tetzlaff, Jane L. Messina, Julie E. Stein, Xiaowei Xu, Rodabe N. Amaria, Christian U. Blank, Bart A. van de Wiel, Peter M. Ferguson, Robert V. Rawson, Merrick I. Ross, Andrew J. Spillane, Jeffrey E. Gershenwald, Robyn P.M. Saw, Alexander C. J. van Akkooi, Winan J. van Houdt, Tara C. Mitchell, Alexander M. Menzies, Georgina V. Long, Jennifer A. Wargo, Michael A. Davies, Víctor G. Prieto, Janis M. Taube, Richard A. Scolyer - Annals of Oncology 2018 cited by 270
- Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial
Authors: Jason Chesney, Igor Puzanov, Frances A. Collichio, Parminder Singh, Mohammed Milhem, John A. Glaspy, Omid Hamid, Merrick I. Ross, Philip Friedlander, Claus Garbe, Theodore F. Logan, Axel Hauschild, Célèste Lebbé, Harshada Joshi, Wendy Snyder, Janice M. Mehnert - Journal for ImmunoTherapy of Cancer 2023 cited by 89
- NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021
Authors: Susan M. Swetter, John A. Thompson, Mark R. Albertini, Christopher A. Barker, Joel Baumgartner, Genevieve M. Boland, Bartosz Chmielowski, Dominick J. DiMaio, Alison B. Durham, Ryan C. Fields, Martin D. Fleming, Anjela Galan, Brian Gastman, Kenneth F. Grossmann, Samantha Guild, Ashley M. Holder, Douglas B. Johnson, Richard W. Joseph, Giorgos C. Karakousis, Kari Kendra, Julie R. Lange, Ryan M. Lanning, Kim Margolin, Anthony J. Olszanski, Patrick A. Ott, Merrick I. Ross, April K.S. Salama, Rohit Sharma, Joseph J. Skitzki, Jeffrey A. Sosman, Evan Wuthrick, Nicole R. McMillian, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2021 cited by 337
- Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial
Authors: Reinhard Dummer, David Gyorki, John Hyngstrom, Adam C. Berger, Robert M. Conry, Lev Demidov, Anjali Sharma, Sheryl Treichel, Hoi-Shen Radcliffe, Kevin Gorski, Abraham Anderson, Emily Chan, Mark B. Faries, Merrick I. Ross - Nature Medicine 2021 cited by 148
- Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
Authors: Christopher P. Vellano, Michael G. White, Miles C. Andrews, Manoj Chelvanambi, Russell G. Witt, Joseph R. Daniele, Mark Titus, Jennifer L. McQuade, Fabio Conforti, Elizabeth M. Burton, Matthew Lastrapes, Gabriel O Ologun, Alexandria P. Cogdill, Golnaz Morad, Peter A. Prieto, Alexander J. Lazar, Yanshuo Chu, Guangchun Han, M.A. Wadud Khan, Beth A. Helmink, Michael A. Davies, Rodabe N. Amaria, Jeffrey J. Kovacs, Scott E. Woodman, Sapna P. Patel, Patrick Hwu, Michael Peoples, Jeffrey E. Lee, Zachary A. Cooper, Haifeng Zhu, Guang R. Gao, Hiya Banerjee, Mike Lau, Jeffrey E. Gershenwald, Anthony Lucci, Emily Z. Keung, Merrick I. Ross, Laura Pala, Eleonora Pagan, Rossana Lazcano Segura, Qian Liu, Mikayla Borthwick, Eric Lau, Melinda S. Yates, Shannon N. Westin, Khalida Wani, Michael T. Tetzlaff, Lauren E. Haydu, Mikhila Mahendra, Xiao-Yan Ma, Christopher J. Logothetis, Zachary Kulstad, Sarah B. Johnson, Courtney W. Hudgens, Ningping Feng, Lorenzo Federico, Georgina V. Long, P. Andrew Futreal, Swathi Arur, Hussein A. Tawbi, Amy E. Moran, Linghua Wang, Timothy P. Heffernan, Joseph R. Marszalek, Jennifer A. Wargo - Nature 2022 cited by 130
- Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients
Authors: Laszlo Radvanyi, Chantale Bernatchez, Minying Zhang, Patricia S. Fox, Priscilla Miller, Jessica Chacon, Richard Wu, Gregory Lizée, Sandy Mahoney, Gladys Alvarado, Michelle R. Glass, Valen E. Johnson, John D. McMannis, Elizabeth J. Shpall, Víctor G. Prieto, Nicholas Papadopoulos, Kevin Kim, Jade Homsi, Agop Y. Bedikian, Wen‐Jen Hwu, Sapna P. Patel, Merrick I. Ross, Jeffrey E. Lee, Jeffrey E. Gershenwald, Anthony Lucci, Richard E. Royal, Janice N. Cormier, Michael A. Davies, Rahmatu Mansaray, Orenthial J. Fulbright, Christopher Toth, Renjith Ramachandran, Seth Wardell, Audrey M. Gonzalez, Patrick Hwu - Clinical Cancer Research 2012 cited by 433
- Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
Authors: Rodabe N. Amaria, Alexander M. Menzies, Elizabeth M. Burton, Richard A. Scolyer, Michael T. Tetzlaff, Robert Antdbacka, Charlotte E. Ariyan, Roland L. Bassett, Brett Carter, Adil Daud, Mark B. Faries, Leslie A. Fecher, Keith T. Flaherty, Jeffrey E. Gershenwald, Omid Hamid, Angela Hong, John M. Kirkwood, Serigne Lo, Kim Margolin, Jane L. Messina, Michael A. Postow, Helen Rizos, Merrick I Ross, Elisa A. Rozeman, Robyn P.M. Saw, Vernon K. Sondak, Ryan J. Sullivan, Janis M. Taube, John F. Thompson, Bart A. van de Wiel, Alexander M.M. Eggermont, Michael A. Davies, Miles C. Andrews, Donald A. Berry, Matthew S. Block, Genevieve M. Boland, Kathryn Bollin, Matteo S. Carlino, Richard D. Carvajal, Jonathan Cohen, Diwakar Davar, Keith A. Delman, Reinhard Dummer, Michael D. Farwell, David E. Fisher, Alberto Fusi, Isabella C. Glitza, Tanja D. de Gruijl, David Gyorki, Axel Hauschild, Tina J. Hieken, James Larkin, David H. Lawson, Célèste Lebbé, Jeffrey E. Lee, Michael Lowe, Jason J. Luke, Grant A. McArthur, David F. McDermott, Jennifer L. McQuade, Tara C. Mitchell, Teresa M. Petrella, Peter A. Prieto, Igor Puzanov, Caroline Robert, April K.S. Salama, Shaneen Sandhu, Dirk Schadendorf, Alexander N. Shoushtari, Jeffrey A. Sosman, Susan M. Swetter, Ken K Tanabe, Samra Turajlic, Douglas S. Tyler, Scott E. Woodman, Frances C. Wright, Jonathan S. Zager, Paolo A. Ascierto, Andrew J. Spillane, Alexander C. J. van Akkooi, Jennifer A. Wargo, Christian U. Blank, Hussein A. Tawbi, Georgina V. Long - The Lancet Oncology 2019 cited by 218
- Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial
Authors: Rodabe N. Amaria, Peter A. Prieto, Michael T. Tetzlaff, Alexandre Reuben, Miles C. Andrews, Merrick I Ross, Isabella C. Glitza, Janice N. Cormier, Wen‐Jen Hwu, Hussein A. Tawbi, Sapna P. Patel, Jeffrey E. Lee, Jeffrey E. Gershenwald, Christine N. Spencer, Vancheswaran Gopalakrishnan, Roland L. Bassett, Lauren Simpson, Rosalind Mouton, Courtney W. Hudgens, Li Zhao, Haifeng Zhu, Zachary A. Cooper, Khalida Wani, Alexander J. Lazar, Patrick Hwu, Adi Diab, Michael K. Wong, Jennifer L. McQuade, Richard E. Royal, Anthony Lucci, Elizabeth M. Burton, Sangeetha M. Reddy, Padmanee Sharma, James P. Allison, Phillip Andrew Futreal, Scott E. Woodman, Michael A. Davies, Jennifer A. Wargo - The Lancet Oncology 2018 cited by 290
- Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome
Authors: Marie‐Andrée Forget, Cara Haymaker, Kenneth R. Hess, Yuzhong Jeff Meng, Caitlin Creasy, Tatiana V. Karpinets, Orenthial J. Fulbright, Jason Roszik, Scott E. Woodman, Young Uk Kim, Donastas Sakellariou-Thompson, Ankit Bhatta, Arely Wahl, Esteban Flores, Shawne T. Thorsen, René J. Tavera, Renjith Ramachandran, Audrey M. Gonzalez, Christopher L. Toth, Seth Wardell, Rahmatu Mansaray, Vruti Patel, Destiny Joy Carpio, Carol Vaughn, Chantell M. Farinas, Portia G. Velasquez, Wen-Jen Hwu, Sapna P. Patel, Michael A. Davies, Adi Diab, Isabella C. Glitza, Hussein A. Tawbi, Michael K. Wong, Suzanne Cain, Merrick I. Ross, Jeffrey E. Lee, Jeffrey E. Gershenwald, Anthony Lucci, Richard E. Royal, Janice N. Cormier, Jennifer A. Wargo, Laszlo Radvanyi, Carlos A. Torres‐Cabala, Rameen Beroukhim, Patrick Hwu, Rodabe N. Amaria, Chantale Bernatchez - Clinical Cancer Research 2018 cited by 135
- Ethnic Differences Among Patients With Cutaneous Melanoma
Authors: Janice N. Cormier, Yan Xing, Meichun Ding, Jeffrey E. Lee, Paul F. Mansfield, Jeffrey E. Gershenwald, Merrick I. Ross, Xianglin L. Du - Archives of Internal Medicine 2006 cited by 379
- Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
Authors: Charles M. Balch, Seng‐Jaw Soong, Jeffrey E. Gershenwald, John F. Thompson, Douglas S. Reintgen, Natale Cascinelli, Marshall M. Urist, Kelly M. McMasters, Merrick I. Ross, John M. Kirkwood, Michael B. Atkins, John A. Thompson, Daniel G. Coit, David R. Byrd, Renée A. Desmond, Yuting Zhang, Ping‐Yu Liu, Gary H. Lyman, Aberto Morabito - Journal of Clinical Oncology 2001 cited by 2,401
- Lymphedema beyond breast cancer
Authors: Janice N. Cormier, Robert L. Askew, Kristi S. Mungovan, Yan Xing, Merrick I. Ross, Jane M. Armer - Cancer 2010 cited by 512
- Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Authors: Daniel G. Coit, John A. Thompson, Mark R. Albertini, Christopher A. Barker, William E. Carson, Carlo M. Contreras, Gregory A. Daniels, Dominick J. DiMaio, Ryan C. Fields, Martin D. Fleming, Morganna Freeman, Anjela Galan, Brian Gastman, Valerie Guild, Douglas B. Johnson, Richard W. Joseph, Julie R. Lange, Sameer K. Nath, Anthony J. Olszanski, Patrick A. Ott, Aparna Priyanath Gupta, Merrick I. Ross, April K.S. Salama, Joseph J. Skitzki, Jeffrey A. Sosman, Susan M. Swetter, Kenneth K. Tanabe, Evan Wuthrick, Nicole R. McMillian, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2019 cited by 438
- Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy
Authors: Henry M. Kuerer, Lisa A. Newman, Terry L. Smith, Fred C. Ames, Kelly K. Hunt, Kapil Dhingra, Richard L. Theriault, Gurpreet Singh, Susan M. Binkley, Nour Sneige, Thomas A. Buchholz, Merrick I. Ross, Marsha D. McNeese, Aman U. Buzdar, Gabriel N. Hortobágyi, S. Eva Singletary - Journal of Clinical Oncology 1999 cited by 1,337
- Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
Authors: Joel Ho, Jane Mattei, Michael T. Tetzlaff, Michelle D. Williams, Michael A. Davies, Adi Diab, Isabella C. Glitza Oliva, Jennifer L. McQuade, Sapna P. Patel, Hussein A. Tawbi, Michael K. Wong, Sarah B. Fisher, Ehab Hanna, Emily Z. Keung, Merrick I. Ross, Roi Weiser, Shirley Y. Su, Michael Frumovitz, Larissa A. Meyer, Amir A. Jazaeri, Curtis A. Pettaway, B. Ashleigh Guadagnolo, Andrew J. Bishop, Devarati Mitra, Ahsan Farooqi, Roland L. Bassett, Silvana C. Faria, Priyadharsini Nagarajan, Rodabe N. Amaria - Frontiers in Oncology 2022 cited by 52
- NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024
Authors: Susan M. Swetter, Douglas B. Johnson, Mark R. Albertini, Christopher A. Barker, Sarah B. Bateni, Joel Baumgartner, Shailender Bhatia, Christopher K. Bichakjian, Genevieve M. Boland, Sunandana Chandra, Bartosz Chmielowski, Dominick J. DiMaio, Roxana Dronca, Ryan C. Fields, Martin D. Fleming, Anjela Galan, Samantha Guild, John Hyngstrom, Giorgos C. Karakousis, Kari Kendra, Maija Kiuru, Julie R. Lange, Ryan M. Lanning, Theodore F. Logan, Daniel G. Olson, Anthony J. Olszanski, Patrick A. Ott, Merrick I. Ross, Luke D. Rothermel, April K.S. Salama, Rohit Sharma, Joseph J. Skitzki, Emily Smith, Katy K. Tsai, Evan Wuthrick, Yan Xing, Nicole R. McMillian, Sara Espinosa - Journal of the National Comprehensive Cancer Network 2024 cited by 125
